Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10073)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2015 (publication date) through Apr 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Seo SI, Kim HS, Kim WJ, Shin WG, Kim DJ, Kim KH, Jang MK, Lee JH, Kim JS, Kim HY, Kim DJ, Lee MS, Park CK. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3928-3935 [PMID: 25852278 DOI: 10.3748/wjg.v21.i13.3928] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i13/3928.htm |
| Number | Citing Articles |
| 1 |
Xiao-Yu Yang, Bin Wu, Sen-Lin Ma, Lei Yin, Meng-Chao Wu, Ai-Jun Li. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery. Technology in Cancer Research & Treatment 2018; 17 doi: 10.1177/1533033818794190
|
| 2 |
Yan Liao, Shengguang Yuan, Xinhuang Chen, Pengpeng Zhu, Jun Li, Liling Qin, Weijia Liao. Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-07962-7
|
| 3 |
Jung Hun Lee, Youe Ree Kim, Guy Mok Lee, Jong Hyun Ryu, Eun Young Cho, Young Hwan Lee, Kwon-Ha Yoon. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B. European Journal of Radiology 2018; 102: 95 doi: 10.1016/j.ejrad.2018.02.032
|
| 4 |
Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2021; 2021(4) doi: 10.1002/14651858.CD013346.pub2
|
| 5 |
Xin Jiang, Afaf Aljbri, Jiaxuan Liu, Liqi Shang, Yulong Tian, Haibo Shao. Hepatic arterial infusion chemotherapy with implantable arterial access port for advanced-stage hepatocellular carcinoma: a case report. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1401882
|
| 6 |
Song-Huy Nguyen-Dinh, Albert Do, Trang Ngoc Doan Pham, Doan Y Dao, Trinh Nhu Nguy, Moon S Chen Jr. High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016. World Journal of Hepatology 2018; 10(1): 116-123 doi: 10.4254/wjh.v10.i1.116
|
| 7 |
Jinlin Hou, Guiqiang Wang, Fusheng Wang, Jun Cheng, Hong Ren, Hui Zhuang, Jian Sun, Lanjuan Li, Jie Li, Qinghua Meng, Jingmin Zhao, Zhongping Duan, Jidong Jia, Hong Tang, Jifang Sheng, Jie Peng, Fengmin Lu, Qing Xie, Lai Wei. Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update). Journal of Clinical and Translational Hepatology 2017; 5(4): 297 doi: 10.14218/JCTH.2016.00019
|
| 8 |
Jiaoxia He, Zhongling Zheng, Tingting Liu, Yupei Ao, Yixuan Yang, Huaidong Hu. Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-18894-2
|
| 9 |
Zhi Wang, Ragini Singh, Carlos Marques, Rajan Jha, Bingyuan Zhang, Santosh Kumar. Taper-in-taper fiber structure-based LSPR sensor for alanine aminotransferase detection. Optics Express 2021; 29(26): 43793 doi: 10.1364/OE.447202
|
| 10 |
Shu An, Xiaoxia Zhan, Min Liu, Laisheng Li, Jian Wu. Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers. Diagnostics 2023; 13(8): 1442 doi: 10.3390/diagnostics13081442
|
| 11 |
Gabriele Ricco, Daniela Cavallone, Chiara Cosma, Gian Paolo Caviglia, Filippo Oliveri, Alessandra Biasiolo, Maria Lorena Abate, Mario Plebani, Antonina Smedile, Ferruccio Bonino, Patrizia Pontisso, Maurizia Rossana Brunetto. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers. Cancer Biomarkers 2018; 21(3): 603 doi: 10.3233/CBM-170551
|
| 12 |
Ayman Yosry, Naglaa Zayed, Reham M Dawood, Marwa K Ibrahim, Marwa Elsharkawy, Sherif M Ekladious, Ahmed Khairy, Aisha Elsharkawy, Marwa Khairy, Shereen Abdel Alem, Noha G Bader El Din, Mostafa K El Awady, Zeinab Abdellatif. Highly Sensitive Serum miRNA Panel for the Diagnosis of Hepatocellular Carcinoma in Egyptian Patients with HCV-Related HCC. Laboratory Medicine 2022; 53(5): 523 doi: 10.1093/labmed/lmac045
|
| 13 |
Hyeongjung Woo, Hyun Young Shin, Minseok S. Kim. Utility and Clinical Value of Circulating Tumor Cells in Gastrointestinal Cancer. Journal of Digestive Cancer Research 2024; 12(2): 106 doi: 10.52927/jdcr.2024.12.2.106
|
| 14 |
Lili Wang, Xiulan Yang, Jinhuan Wang, Guoying Yu. Predictive value of PIVKA-II and AFP for the non-objective response of HBV-associated hepatocellular carcinoma after transarterial chemoembolization: a prospective study. European Journal of Gastroenterology & Hepatology 2023; 35(12): 1410 doi: 10.1097/MEG.0000000000002663
|
| 15 |
Xiaofeng Hang, Zhiqin Wu, Kaijian Chu, Guanzhen Yu, Haoran Peng, Haiguang Xin, Xiaohui Miao, Junxue Wang, Wensheng Xu. Low expression of DCXR protein indicates a poor prognosis for hepatocellular carcinoma patients. Tumor Biology 2016; 37(11): 15079 doi: 10.1007/s13277-016-5302-9
|
| 16 |
Ping Luo, Sanyun Wu, Yalan Yu, Xinliang Ming, Shuo Li, Xuelan Zuo, Jiancheng Tu. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage. Pathology & Oncology Research 2020; 26(2): 599 doi: 10.1007/s12253-019-00585-5
|
| 17 |
Li He, Cui Zhang, Lan-Lan Liu, Li-Ping Huang, Wen-Jing Lu, Yuan-Yuan Zhang, De-Yong Zou, Yu-Fei Wang, Qing Zhang, Xiao-Li Yang. Development of a diagnostic nomogram for alpha-fetoprotein-negative hepatocellular carcinoma based on serological biomarkers. World Journal of Gastrointestinal Oncology 2024; 16(6): 2463-2475 doi: 10.4251/wjgo.v16.i6.2463
Abstract(300) |
Core Tip(336) |
Full Article(HTML)(1220)
|
Full Article with Cover (PDF)-1890K(149)
|
Audio-1381K(2)
|
Peer-Review Report-217K(47)
|
Answering Reviewers-49K(46)
|
Supplementary Material-199K(51)
|
Full Article (PDF)-1577K(74)
|
Full Article (XML)-128K(52)
|
Times Cited (0)
|
Total Visits (3614)
|
Open
|
| 18 |
Tanita Suttichaimongkol, Manoon Mitpracha, Kawin Tangvoraphonkchai, Phuangphaka Sadeea, Kittisak Sawanyawisuth, Wattana Sukeepaisarnjaroen. PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients. Journal of Circulating Biomarkers 2023; 12: 12 doi: 10.33393/jcb.2023.2453
|
| 19 |
Bingqiang Zhang, Xiaoyan Ma, Yang Zhou, Boyang Zhu, Junmei Yu, He Liu, Yongchao Ma, Yansong Luan, Mengmeng Chen. Diagnostic Value of Circulating microRNAs for Hepatocellular Carcinoma: Results of a Meta-analysis and Validation. Biochemical Genetics 2025; doi: 10.1007/s10528-024-11001-2
|
| 20 |
Zeyu Tian, Tanbo Yu, Hongyan Wei, Ning Ning. Clinical value of LHPP‐associated microRNAs combined with protein induced by vitamin K deficiency or antagonist‐II in the diagnosis of alpha‐fetoprotein‐negative hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2020; 34(2) doi: 10.1002/jcla.23071
|
| 21 |
Gian Paolo Caviglia, Michela Ciruolo, Maria Lorena Abate, Patrizia Carucci, Emanuela Rolle, Chiara Rosso, Antonella Olivero, Giulia Troshina, Alessandra Risso, Aurora Nicolosi, Davide Giuseppe Ribaldone, Angelo Armandi, Francesco Tandoi, Giorgio Maria Saracco, Elisabetta Bugianesi, Alessia Ciancio, Silvia Gaia. Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology. Cancers 2020; 12(11): 3218 doi: 10.3390/cancers12113218
|
| 22 |
Shi-Tao Wu, Li Zhu, Xiao-Ling Feng, Hao-Yu Wang, Fang Li. Strategies for discovering novel hepatocellular carcinoma biomarkers. World Journal of Hepatology 2025; 17(2): 101201 doi: 10.4254/wjh.v17.i2.101201
|
| 23 |
Yanping Tang, Kezhi Li, Zhengmin Cai, Yuxuan Xie, Xiaoyu Tan, Chenglin Su, Jilin Li. Hsp90α Combined with Afp and Tk1 Improved the Diagnostic Value for Hepatocellular Carcinoma. Biomarkers in Medicine 2020; 14(10): 869 doi: 10.2217/bmm-2019-0484
|
| 24 |
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. International Journal of Molecular Sciences 2023; 24(5): 4286 doi: 10.3390/ijms24054286
|
| 25 |
Xiumei Wang, Weiwei Zhang, Youde Liu, Wenjing Gong, Ping Sun, Xiangshuo Kong, Miaomiao Yang, Zhihua Wang. Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0153-6
|
| 26 |
Tyng-Yuan Jang, Chia-Yen Dai. Cutoff values of protein induced by vitamin K absence or antagonist II for diagnosing hepatocellular carcinoma. Medicine 2022; 101(39): e30936 doi: 10.1097/MD.0000000000030936
|
| 27 |
Lijun Wan, Li Guo, Youwen Hu, Hongyan Huang, Moran Zhang, Kedong Xu, Gejirifu De, Fengfei Zheng, Zhengqiang Wu, Chungen Hu, Zhili Wen. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer. Clinical Biochemistry 2021; 89: 44 doi: 10.1016/j.clinbiochem.2020.12.005
|
| 28 |
S Dahlberg, U Schött. Vitamin K: A potential Liver Cancer treatment way. Archives of Hepatitis Research 2017; 3(1): 049 doi: 10.17352/ahr.000017
|
| 29 |
Wenfeng Zhu, Weilong Wang, Wenjie Zheng, Xiaolong Chen, Xiaowen Wang, Juping Xie, Shijie Jiang, Haoqi Chen, Shuguang Zhu, Ping Xue, Xiaofeng Jiang, Hua Li, Genshu Wang. Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59174-5
|
| 30 |
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, Pengde Lu, Lin Xu, Hongchao Yuan, Yibin Feng, Zhe-Sheng Chen, Ning Wang. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02101-z
|
| 31 |
Deepti Sharma, Babu Lal Meena, Hanuman Prasad Yadav, Guresh Kumar, Anju K. V, Deepak Jagya, Shiv Kumar Sarin. Predictive factors and nomogram (MAP-BNP) for post stereotactic body radiotherapy survival in advanced hepatocellular carcinoma patients. Journal of Clinical and Experimental Hepatology 2025; : 102555 doi: 10.1016/j.jceh.2025.102555
|
| 32 |
John Grady, Neehar D. Parikh. Update on HCC Surveillance in Patient With Hepatitis B Virus Infection With Focus on Biomarkers. Current Hepatology Reports 2024; 23(1): 1 doi: 10.1007/s11901-024-00631-0
|
| 33 |
Nurbubu Moldogazieva, Innokenty Mokhosoev, Sergey Zavadskiy, Alexander Terentiev. Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine. Biomedicines 2021; 9(2): 159 doi: 10.3390/biomedicines9020159
|
| 34 |
Yuan-Quan Si, Xiu-Qin Wang, Gang Fan, Chang-Yin Wang, Yuan-Wen Zheng, Xie Song, Cui-Cui Pan, Fu-Lu Chu, Zhan-Feng Liu, Bing-Ru Lu, Zhi-Ming Lu. Value of AFP and PIVKA-II in diagnosis of HBV-related hepatocellular carcinoma and prediction of vascular invasion and tumor differentiation. Infectious Agents and Cancer 2020; 15(1) doi: 10.1186/s13027-020-00337-0
|
| 35 |
Chih-Yang Hsiao, Chang-Yi Lu, Hung-Ju Su, Kai-Wen Huang. Plasma Cell-Free Adenomatous Polyposis Coli Gene Promoter Methylation as a Prognostic Biomarker for Hepatocellular Carcinoma. Oncology 2024; 102(11): 935 doi: 10.1159/000538455
|
| 36 |
Mingda Wang, Guojun Qian, Hongmei Xiao, Xingkai Liu, Liyang Sun, Zhong Chen, Kongying Lin, Lanqing Yao, Chao Li, Lihui Gu, Jiahao Xu, Xiaodong Sun, Wei Qiu, Timothy M Pawlik, Wan Yee Lau, Guoyue Lv, Feng Shen, Tian Yang. Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients. The Oncologist 2024; 29(12): e1723 doi: 10.1093/oncolo/oyae139
|
| 37 |
Kurataka Otsuka, Takahiro Ochiya. Possible connection between diet and microRNA in cancer scenario. Seminars in Cancer Biology 2021; 73: 4 doi: 10.1016/j.semcancer.2020.11.014
|
| 38 |
Guiqiang Wang, Zhongping Duan. Guidelines for Prevention and Treatment of Chronic Hepatitis B. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00209
|
| 39 |
Hana Hadi, Wan Muhammad Azfar Wan Shuaib, Raja Affendi Raja Ali, Hanita Othman. Utility of PIVKA-II and AFP in Differentiating Hepatocellular Carcinoma from Non-Malignant High-Risk Patients. Medicina 2022; 58(8): 1015 doi: 10.3390/medicina58081015
|
| 40 |
Nahyun Cho, Hye-ri Bae, Nam-hun Lee. 15-Year Long-Term Follow-Up on the Progression to Liver Cancer in a Patient with Alcoholic Hepatitis Who Continued Drinking: A Case Report and Clinical Approach. The Journal of Internal Korean Medicine 2024; 45(4): 823 doi: 10.22246/jikm.2024.45.4.823
|
| 41 |
Rong Wen, Yuting Peng, Yiqiong Liang, Yuquan Wu, Haiyuan Li, Yanxia Chen, Yan Qin, Zhiyuan Wen, Huanyu Cui, Yun He, Hong Yang. CEUS LI-RADS in Combination With the Serum Biomarker-Based ASAP Model Improves the Diagnostic Performance of HCC in High-Risk Patients. Ultrasound in Medicine & Biology 2024; 50(11): 1739 doi: 10.1016/j.ultrasmedbio.2024.08.003
|
| 42 |
Suhad Mohammed Mahmoud, Athraa Zaidan Hassan, Salah Mahdi Hassan, Safaa Abdulkareem Alwaysi. Determination of Alpha-fetoprotein, Golgi protein-73 and Glypican-3 Levels in Chronic Viral Hepatitis B Patients with Fibrosis in Baghdad Gastroenterology and Hepatology Hospital. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) 2025; 8(2(Special)): 23 doi: 10.54133/ajms.v8i2(Special).1401
|
| 43 |
Sugan Panneerselvam, Cornelia Wilson, Prem Kumar, Dinu Abirami, Jayakrishna Pamarthi, Mettu Srinivas Reddy, Joy Varghese. Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options. Cell Adhesion & Migration 2023; 17(1): 1 doi: 10.1080/19336918.2023.2258539
|
| 44 |
Ming-Da Wang, Li-Yang Sun, Guo-Jun Qian, Chao Li, Li-Hui Gu, Lan-Qing Yao, Yong-Kang Diao, Timothy M. Pawlik, Wan Yee Lau, Dong-Sheng Huang, Feng Shen, Tian Yang. Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: A retrospective cohort study. International Journal of Surgery 2022; 105: 106843 doi: 10.1016/j.ijsu.2022.106843
|
| 45 |
Qiang Wang, Qi Chen, Xia Zhang, Xiao-Lan Lu, Qin Du, Tao Zhu, Guo-Yuan Zhang, Dong-Sheng Wang, Qu-Ming Fan. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(36): 5515-5529 doi: 10.3748/wjg.v25.i36.5515
|
| 46 |
Guoxu Fang, Jianhui Fan, Zongren Ding, Yongyi Zeng. Application of biological big data and radiomics in hepatocellular carcinoma. iLIVER 2023; 2(1): 41 doi: 10.1016/j.iliver.2023.01.003
|
| 47 |
Muhammad Ali Qadeer, Zaigham Abbas, Shaima Amjad, Bushra Shahid, Abeer Altaf, Mehreen Siyal. Des-gamma-carboxy prothrombin and alpha-fetoprotein levels as biomarkers for hepatocellular carcinoma and their correlation with radiological characteristics. World Journal of Gastrointestinal Pathophysiology 2024; 15(1): 90893 doi: 10.4291/wjgp.v15.i1.90893
|
| 48 |
Huaping Chen, Siyuan Chen, Shan Li, Zhijian Chen, Xuan Zhu, Meiyu Dai, Lingxi Kong, Xiaodan Lv, Zhili Huang, Xue Qin. Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study. Oncotarget 2017; 8(52): 90390 doi: 10.18632/oncotarget.20153
|
| 49 |
Jonas Holdmann, Andreas Savelsbergh, Lukas Markert. miRNAs, Human Health and Diseases. Epigenetics and Human Health 2024; 13: 131 doi: 10.1007/978-3-031-64788-8_6
|
| 50 |
Norhanan Hamzah, Nur Karyatee Kassim, Julia Omar, Mohd Shafie Abdullah, Yeong Yeh Lee. Levels of PIVKA-II and alpha-fetoprotein in unresectable hepatocellular carcinoma compared to healthy controls and predictive values of both markers with radiological responses after loco-regional interventions. PeerJ 2023; 11: e15988 doi: 10.7717/peerj.15988
|
| 51 |
Yusuke Yamamoto, Shunsuke Kondo, Juntaro Matsuzaki, Minoru Esaki, Takuji Okusaka, Kazuaki Shimada, Yoshiki Murakami, Masaru Enomoto, Akihiro Tamori, Ken Kato, Yoshiaki Aoki, Satoko Takizawa, Hiromi Sakamoto, Shumpei Niida, Fumitaka Takeshita, Takahiro Ochiya. Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease. Hepatology Communications 2020; 4(2): 284 doi: 10.1002/hep4.1451
|
| 52 |
Daria Korolova, Viktoriya Gryshchenko, Tamara Chernyshenko, Oleh Platonov, Olha Hornytska, Volodymyr Chernyshenko, Pavlo Klymenko, Yevdokiia Reshetnik, Tetyana Platonova. Blood coagulation factors and platelet response to drug‐induced hepatitis and hepatosis in rats. Animal Models and Experimental Medicine 2023; 6(1): 66 doi: 10.1002/ame2.12301
|
| 53 |
Dong Hyun Kim, Eun Min Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Gi Hong Choi, Sang Hoon Ahn, Hye Won Lee, Do Young Kim. Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma. Cancers 2025; 17(4): 566 doi: 10.3390/cancers17040566
|
| 54 |
Amit Yelsangikar, Prachi S. Patil. Redefining HCC Surveillance in India: A Call for Innovative and Inclusive Strategies. Journal of Clinical and Experimental Hepatology 2024; 14(6): 101474 doi: 10.1016/j.jceh.2024.101474
|
| 55 |
Yusuke Yamamoto, Isaku Kohama, Takahiro Ochiya. The Liver. 2020; : 183 doi: 10.1002/9781119436812.ch16
|
| 56 |
Alessandro Loglio, Massimo Iavarone, Floriana Facchetti, Dhanai Di Paolo, Riccardo Perbellini, Giovanna Lunghi, Ferruccio Ceriotti, Claudio Galli, Maria T. Sandri, Mauro Viganò, Angelo Sangiovanni, Massimo Colombo, Pietro Lampertico. The combination of PIVKA‐II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long‐term oral therapy. Liver International 2020; 40(8): 1987 doi: 10.1111/liv.14475
|
| 57 |
Honglei Feng, Bole Li, Ze Li, Qian Wei, Li Ren. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08138-3
|
| 58 |
Qiyao Zhang, Qingyuan Zheng, Xiao Yu, Yuting He, Wenzhi Guo. Overview of distinct 5-methylcytosine profiles of messenger RNA in human hepatocellular carcinoma and paired adjacent non-tumor tissues. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02417-6
|
| 59 |
Maiko Machida, Mayuko Ambo, Runa Mishina, Nanaka Hada, Fuhito Tachibana, Miki Yamashita, Ainari Konda, Kunihiko Tsuji. Integrated Predictors by Propensity Scoring With Tumor Markers and Plasma Levels of microRNA-21-5p, IL-17, and IL-10 Complement Early Detection of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231212084
|
| 60 |
Jiu Chen, Guolin Wu, Youdi Li. Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis. Disease Markers 2018; 2018: 1 doi: 10.1155/2018/8906023
|
| 61 |
Miaoxia Liu, Ruihong Wu, Xu Liu, Hongqin Xu, Xiumei Chi, Xiaomei Wang, Mengru Zhan, Bao Wang, Fei Peng, Xiuzhu Gao, Ying Shi, Xiaoyu Wen, Yali Ji, Qinglong Jin, Junqi Niu. <p>Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients</p>. Journal of Hepatocellular Carcinoma 2020; : 219 doi: 10.2147/JHC.S271790
|
| 62 |
Vandana M. Sagar, Kathyrn Herring, Stuart Curbishley, James Hodson, Peter Fletcher, Salil Karkhanis, Homoyon Mehrzad, Pankaj Punia, Tahir Shah, Shishir Shetty, Yuk Ting Ma. The potential of PIVKA-II as a treatment response biomarker in hepatocellular carcinoma: a prospective United Kingdom cohort study. Oncotarget 2021; 12(24): 2338 doi: 10.18632/oncotarget.28136
|
| 63 |
Fang Peng, Hao Yuan, Yi-Feng Zhou, Si-Xian Wu, Zhen-Yi Long, Ya-Meng Peng. Diagnostic Value of Combined Detection via Protein Induced by Vitamin K Absence or Antagonist II, Alpha-Fetoprotein, and D-Dimer in Hepatitis B Virus-Related Hepatocellular Carcinoma. International Journal of General Medicine 2022; : 5763 doi: 10.2147/IJGM.S362359
|
| 64 |
Carlo Saitta, Giuseppina Raffa, Angela Alibrandi, Santa Brancatelli, Daniele Lombardo, Gianluca Tripodi, Giovanni Raimondo, Teresa Pollicino. PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients. Medicine 2017; 96(26): e7266 doi: 10.1097/MD.0000000000007266
|
| 65 |
Richa Surit, Ravi Shekhar, Dinesh Kumar Sinha, Sanjeet Kumar Singh, Uday Kumar, Nidhi Prasad. Hepatitis B in hepatocellular carcinoma patients and its correlation with alpha-fetoprotein and liver enzymes. Journal of Cancer Research and Therapeutics 2022; 18(4): 903 doi: 10.4103/jcrt.JCRT_239_19
|
| 66 |
Roya Solhi, Mahsa Pourhamzeh, Ali Zarrabi, Moustapha Hassan, Hamed Mirzaei, Massoud Vosough. Novel biomarkers for monitoring and management of hepatocellular carcinoma. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03600-1
|
| 67 |
Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan. Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region. Clinical and Molecular Hepatology 2023; 29(2): 277 doi: 10.3350/cmh.2022.0212
|
| 68 |
Nia Adeniji, Renumathy Dhanasekaran. Current and Emerging Tools for Hepatocellular Carcinoma Surveillance. Hepatology Communications 2021; 5(12): 1972 doi: 10.1002/hep4.1823
|
| 69 |
Rentao Yu, Xiaomei Xiang, Zhaoxia Tan, Yi Zhou, Haoliang Wang, Guohong Deng. Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients. Scientific Reports 2016; 6(1) doi: 10.1038/srep35050
|